| Mitomycin |
20160162 |
Mitomycin Accord, powder for solution for injection/infusion or intravesical use, 20, mg, Pack: 1 vial |
Accord Healthcare Polska Sp. z.o.o., Полша |
Accord Healthcare Limited, Обединено кралство |
51.95 |
10.39 |
62.34 |
4% |
2.08 |
54.03 |
10.81 |
64.84 |
16% |
8.31 |
62.34 |
12.47 |
74.81 |
|
НСР-20492/23.12.2019 Предварително изпълнение |
23.12.2019 |
02.01.2020 |
Активен |
16010 |
| Mitomycin |
ІІ-4219/16.02.2009 г. |
Mitomycin-C Kyowa, Solution for injection, 2, mg, Pack: 10 |
Kyowa Hakko Kirin UK Ltd., Обединено Кралство |
Kyowa Hakko Kirin Co Ltd., Япония |
47.04 |
9.41 |
56.45 |
6% |
2.82 |
49.86 |
9.97 |
59.83 |
18% |
8.47 |
58.33 |
11.67 |
70 |
цената е заличена с решение КЦРР-797/15.06.2012 |
КЦ-403/07.01.2009; корек. КЦ-498/06.02.2009 |
24.07.2012 |
24.07.2012 |
Заличен |
429 |
| Mitomycin |
20040100 |
Mitomycin-C Kyowa, Solution for injection, 20, mg, Pack: 1 |
Nordic Pharma s.r.o., Чешка република |
Nordic Pharma s.r.o. Чехия |
42.77 |
8.55 |
51.32 |
4% |
1.71 |
44.48 |
8.9 |
53.38 |
16% |
6.84 |
51.32 |
10.26 |
61.58 |
|
HCР-513/11.07.2013.; НСР-12094/27.03.2017 |
29.07.2013 |
02.05.2017 |
Заличен |
1948 |
| Mitomycin |
20040100 |
Mitomycin-C Kyowa, Solution for injection, 20, mg, Pack: 1 |
Nordic Pharma s.r.o., Чешка република |
Nordic Pharma s.r.o. Чехия |
42.77 |
8.55 |
51.32 |
4% |
1.71 |
44.48 |
8.9 |
53.38 |
16% |
6.84 |
51.32 |
10.26 |
61.58 |
|
HCР-513/11.07.2013. |
29.07.2013 |
29.07.2013 |
Неактивен |
1948 |
| Mitomycin |
ІІ-4221/ 16.02.2009 г. |
Mitomycin-C Kyowa, Solution for injection, 20, mg, Pack: 1 |
Nordic Pharma s.r.o., Чешка република |
Nordic Pharma s.r.o. Чехия |
41.93 |
8.39 |
50.32 |
4% |
1.68 |
43.61 |
8.72 |
52.33 |
16% |
6.71 |
50.32 |
10.06 |
60.38 |
промяна на обстоятелства решение КЦPP-456/19.04.2012 |
КЦРР-552/04.05.2012 |
21.05.2012 |
21.05.2012 |
Неактивен |
1948 |
| Mitomycin |
ІІ-4221/16.02.2009 г. |
Mitomycin-C Kyowa, Solution for injection, 20, mg, Pack: 1 |
Nordic Pharma s.r.o., Чешка република |
Nordic Pharma s.r.o. Чехия |
47.72 |
9.54 |
57.26 |
6% |
2.86 |
50.58 |
10.12 |
60.7 |
18% |
8.59 |
59.17 |
11.83 |
71 |
промяна на обстоятелства решение КЦ-812/15.04.2009; КЦРР-406/29.03.2012 |
КЦ-403/07.01.2009; корек. КЦ-498/06.02.2009 |
02.02.2009 |
02.02.2009 |
Неактивен |
1948 |
| Mitomycin |
ІІ-4220/16.02.2009 г. |
Mitomycin-C Kyowa, Solution for injection, 10, mg, Pack: 1 |
Nordic Pharma s.r.o., Чешка република |
Nordic Pharma s.r.o. Чехия |
26.21 |
5.24 |
31.45 |
6% |
1.57 |
27.78 |
5.56 |
33.34 |
18% |
4.72 |
32.5 |
6.5 |
39 |
промяна на обстоятелства решение КЦ-812/15.04.2009; КЦРР-456/19.04.2012; цената е заличена с решение НСР-4780/ 13.10.2014 (влиза в сила от 27.10.2014 ) |
КЦ-403/07.01.2009; корек. КЦ-498/06.02.2009 |
02.02.2009 |
02.02.2009 |
Заличен |
430 |
| Mitoxantrone |
20050260 |
MITOXANTRON "EBEWE", Concentrate for solution for infusion, 2 mg/ml - 10 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
54.24 |
10.85 |
65.09 |
4% |
2.17 |
56.41 |
11.28 |
67.69 |
16% |
8.68 |
65.09 |
13.02 |
78.11 |
промяна на обстоятелства НСР-10531/06.10.2016 |
НСР-1986/06.12.2013; НСР-20911/27.02.2020 |
13.03.2020 |
02.04.2020 |
Активен |
2338 |
| Mitoxantrone |
20050260 |
MITOXANTRON "EBEWE", Concentrate for solution for infusion, 2 mg/ml - 10 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
50.09 |
10.02 |
60.11 |
4% |
2 |
52.09 |
10.42 |
62.51 |
16% |
8.01 |
60.1 |
12.02 |
72.12 |
промяна на обстоятелства НСР-10531/06.10.2016 |
НСР-1986/06.12.2013 |
24.12.2013 |
02.11.2016 |
Неактивен |
2338 |
| Mitoxantrone |
ІІ-10773/04.05.2005 г. |
MITOXANTRON "EBEWE", Concentrate for solution for infusion, 2 mg/ml - 10 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
50.09 |
10.02 |
60.11 |
4% |
2 |
52.09 |
10.42 |
62.51 |
16% |
8.01 |
60.1 |
12.02 |
72.12 |
|
НСР-1986/06.12.2013 |
24.12.2013 |
24.12.2013 |
Неактивен |
2338 |
| Mitoxantrone |
ІІ-10773/04.05.2005 г. |
MITOXANTRON "EBEWE", Concentrate for solution for infusion, 2 mg/ml - 5 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
45.86 |
9.17 |
55.03 |
4% |
1.83 |
47.69 |
9.54 |
57.23 |
16% |
7.34 |
55.03 |
11.01 |
66.04 |
Цената се заличава с решение НСР-3012/12.03.2014 |
НСР-1987/06.12.2013 |
24.12.2013 |
24.12.2013 |
Заличен |
2339 |
| Mitoxantrone |
ІІ-10773/04.05.2005 г. |
MITOXANTRON "EBEWE", Concentrate for solution for infusion, 2 mg/ml - 10 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
174.32 |
34.86 |
209.18 |
4% |
6.97 |
181.29 |
36.26 |
217.55 |
16% |
25 |
206.29 |
41.26 |
247.55 |
|
КЦ-1296/21.01.2010 |
07.02.2010 |
07.02.2010 |
Неактивен |
2338 |
| Mitoxantrone |
ІІ-10773/04.05.2005 г. |
MITOXANTRON "EBEWE", Concentrate for solution for infusion, 2 mg/ml - 5 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
97.62 |
19.52 |
117.14 |
4% |
3.9 |
101.52 |
20.3 |
121.82 |
16% |
15.62 |
117.14 |
23.43 |
140.57 |
|
КЦ-1296/21.01.2010 |
07.02.2010 |
07.02.2010 |
Неактивен |
2339 |
| Indapamide |
20080049 |
Mivara SR, Prolonged release tablet, 1.5, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Stada Arzneimittel AG, Германия, Centrafarm Services, Netherlands, Stada Production Ireland, Ireland |
2.78 |
0.56 |
3.34 |
7% |
0.19 |
2.97 |
0.59 |
3.56 |
20% |
0.56 |
3.53 |
0.71 |
4.24 |
|
КЦРР-2180/06.02.2013 г |
25.02.2013 |
25.02.2013 |
Активен |
1629 |
| Indapamide |
20080049 |
Mivara SR, Prolonged release tablet, 1.5, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Stada Arzneimittel AG, Германия, Centrafarm Services, Netherlands, Stada Production Ireland, Ireland |
2.78 |
0.56 |
3.34 |
7% |
0.19 |
2.97 |
0.59 |
3.56 |
20% |
0.56 |
3.53 |
0.71 |
4.24 |
|
КЦРР-2180/06.02.2013 г |
25.02.2013 |
25.02.2013 |
Неактивен |
1629 |
| Indapamide |
2419/04,07,2008 |
Mivara SR, Prolonged release tablet, 1.5, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Stada Arneimittel AG, Germany; Centrafarm Services B.v. - The Netherland; Stada Production Ireland Ltd. - Ireland |
3.72 |
0.74 |
4.46 |
7% |
0.26 |
3.98 |
0.8 |
4.78 |
20% |
0.74 |
4.72 |
0.94 |
5.66 |
|
КЦРР-787/15.06.2012 |
02.07.2012 |
02.07.2012 |
Неактивен |
1629 |
| Indapamide |
2419/04,07,2008 |
Mivara SR, Prolonged release tablet, 1.5, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Stada Arneimittel AG, Germany; Centrafarm Services B.v. - The Netherland; Stada Production Ireland Ltd. - Ireland |
4.11 |
0.82 |
4.93 |
9% |
0.37 |
4.48 |
0.9 |
5.38 |
22% |
0.9 |
5.38 |
1.08 |
6.46 |
корекц. КЦ-778/07.04.2009 |
КЦ-759/31.03.2009 |
18.04.2009 |
18.04.2009 |
Неактивен |
1629 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Suspension for injection, 100 IU/ml - 3 ml, -, Pack: 5 cartridges |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
39.31 |
7.86 |
47.17 |
4% |
1.57 |
40.88 |
8.18 |
49.06 |
16% |
6.29 |
47.17 |
9.43 |
56.6 |
Протокол №200/01.12.2016 |
НСР-6606/01.07.2015; НСР-10333/15.09.2016 |
01.10.2016 |
02.12.2016 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Suspension for injection, 100 IU/ml - 3 ml, -, Pack: 5 cartridges |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
38.2 |
7.64 |
45.84 |
4% |
1.53 |
39.73 |
7.95 |
47.68 |
16% |
6.11 |
45.84 |
9.17 |
55.01 |
Протокол №200/01.12.2016 |
НСР-6606/01.07.2015; НСР-10333/15.09.2016; НСР-14764/22.12.2017; НСР-18136/07.03.2019 |
22.03.2019 |
02.04.2019 |
Активен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Suspension for injection, 100 IU/ml - 3 ml, -, Pack: 5 cartridges |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
38.28 |
7.66 |
45.94 |
4% |
1.53 |
39.81 |
7.96 |
47.77 |
16% |
6.12 |
45.93 |
9.19 |
55.12 |
Протокол №200/01.12.2016 |
НСР-6606/01.07.2015; НСР-10333/15.09.2016; НСР-14764/22.12.2017 |
12.01.2018 |
02.02.2018 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
39.31 |
7.86 |
47.17 |
4% |
1.57 |
40.88 |
8.18 |
49.06 |
16% |
6.29 |
47.17 |
9.43 |
56.6 |
|
НСР-6606/01.07.2015; НСР-10333/15.09.2016 |
02.11.2016 |
02.11.2016 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
39.53 |
7.91 |
47.44 |
4% |
1.58 |
41.11 |
8.22 |
49.33 |
16% |
6.32 |
47.43 |
9.49 |
56.92 |
|
НСР-6606/01.07.2015 |
17.07.2015 |
17.07.2015 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
39.53 |
7.91 |
47.44 |
4% |
1.58 |
41.11 |
8.22 |
49.33 |
16% |
6.32 |
47.43 |
9.49 |
56.92 |
|
НСР-6606/01.07.2015 |
17.07.2015 |
17.07.2015 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
39.94 |
7.99 |
47.93 |
4% |
1.6 |
41.54 |
8.31 |
49.85 |
16% |
6.39 |
47.93 |
9.59 |
57.52 |
|
НСР-3423/30.04.2014 |
22.05.2014 |
22.05.2014 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
40.8 |
8.16 |
48.96 |
4% |
1.63 |
42.43 |
8.49 |
50.92 |
16% |
6.53 |
48.96 |
9.79 |
58.75 |
|
НСР-1035/23.08.2013 |
17.09.2013 |
17.09.2013 |
Неактивен |
2777 |